Premium
ADHD drugs linked to reduced risk of depression in national cohort study
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30218
Subject(s) - depression (economics) , cohort , psychiatry , attention deficit hyperactivity disorder , medicine , psychopharmacology , cohort study , psychology , economics , macroeconomics
A nationwide cohort study of individuals with attention‐deficit hyperactivity disorder (ADHD) in Sweden has found no association between ADHD medication and later risk of depression. Instead, depression risk actually was lower in individuals receiving an ADHD drug, the researchers reported. Study results were published Dec. 15, 2016, in Biological Psychiatry .